The Beyond Celiac Newsletter

Monthly Newsletter

Corn Puff Toffee Treat

Caution! This gluten-free treat is highly addicting! Renowned gluten-free chef Oonagh Williams takes us through her caramel corn puff recipe which would be great for celebrating Valentine’s Day or the Super Bowl.

 

Crustless Quiche: A Healthier Quiche Option

It’s all in the title. Enjoy this recipe without having to worry about the added crust, heavy cream, or the extra eggs often added to typical heavy quiche recipes. This is a tasty, health-conscious dish that works for breakfast or bunch, or hey, even lunch and dinner!

About Chef Oonagh Williams

Read more research news on our Research News Feed

Clinical Trials

ACeD Study

Do you, or someone you know, have celiac disease? The ACeD study is looking for volunteers with celiac disease to participate in phase 1 clinical trial testing the investigational drug KAN-101.

Requirements:

  • 18-70 years old
  • Biopsy-confirmed celiac disease
  • On gluten-free diet for at least the last 12 months

Get More Information

CeDLara Study

Still experiencing symptoms on a gluten-free diet? The CeDLara Study is currently enrolling qualified patients into their phase 3 study to assess a potential therapy for celiac disease. This study is being conducted to determine if the drug reduces symptoms of celiac disease in patients who are on a gluten-free diet. You may qualify to participate in this study if you:

  • Are 18 years old or older
  • Are biopsy diagnosed with celiac disease
  • Are actively experiencing symptoms related to celiac disease such as abdominal pain, abdominal cramping, bloating or gas
  • Have been on a gluten-free diet for at least 6 months

Learn More

PROACTIVE Study

Are you still experiencing celiac disease symptoms despite your best efforts to follow a gluten-free diet?

The PROACTIVE Celiac Study is looking for people between the ages of 18 and 70, who have biopsy-confirmed celiac disease and have been on a gluten-free diet for at least the last 12 months. You will not be asked to ingest gluten in this study. The goal of this phase 2 clinical trial is to test the safety and effects of the investigational medication PRV-015. In combination with a gluten-free diet, PRV-015 aims to reduce symptoms and intestinal inflammation caused by accidental gluten exposure.

Learn More
See if You Qualify
Use referral code: REFBC

Solutions for Celiac Study

The Solutions for Celiac study is researching a drink-based study medication and its ability to reduce symptoms of accidental gluten exposure. Latiglutenase is a study medication designed to break down gluten into inactive pieces in the stomach to protect people with celiac disease. No uncomfortable biopsies or injections.

Locations: Chattanooga, TN | New York, NY | Chesterfield, MI | Rochester, MN

Learn More



Allergic Living Spotlight

FDA Gets Tough on Whole Foods

The U.S. Food and Drug Administration has sent a stern warning letter to the president of Whole Foods Market, slamming the national food retailer for allergen recalls of 32 food products in the past year.


News, Events & Updates

Think you may have celiac disease?

Symptoms Checklist